About this Research Topic
Frontiers has organized a series of Research Topics to highlight the latest advancements in research across the field of Lupus, with articles from the members of our accomplished Editorial Boards. This editorial initiative of particular relevance, led by Prof Elena M Massarotti, Specialty Chief Editor of the Disease Mechanisms in Lupus section, together with Dr., is focused on new insights, novel developments, current challenges, latest discoveries, recent advances, and future perspectives in the field of Clinical Research and Treatment in Lupus .
The Research Topic solicits brief, forward-looking contributions from the editorial board members that describe the state of the art, outlining recent developments and major accomplishments that have been achieved and that need to occur to move the field forward. Authors are encouraged to identify the greatest challenges in the sub-disciplines, and how to address those challenges. Submissions covering all areas of Clinical Research and Treatment in Lupus are welcome and those covering the following themes are encouraged:
1. New clinical therapeutics
2. New and emerging treatments
3. Novel trial designs
4. Clinical trials
5. Management and treatment of comorbidities
The goal of this special edition Research Topic is to shed light on the progress made in the past decade in the Clinical Research and Treatment in Lupus, and on its future challenges to provide a thorough overview of the field. This article collection will inspire, inform and provide direction and guidance to researchers in the field.
This Research Topic is part of the Frontiers in Lupus Insights series. Other titles in the series are:
• Insights in Disease mechanisms in Lupus
• Insights in Epidemiology of Lupus
• Insights in Translational Immunology and Pre-Clinical Models
Keywords: SLE, Lupus, Clinical trials
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.